Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Business & Industry
- Pfizer and BioNTech granted FDA Fast Track designation for two investigational mRNA-based vaccine candidates against SARS-CoV-2
- Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients
- GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
- Merck initiates first clinical trial of TLR7 and 8 inhibitor as a potential treatment for severe symptoms of COVID-19 infection
- Novartis resolves legacy litigation matters, finalizing settlement of speaker program litigation with Government in the US
Research & Development
- Common FDA-approved drug may effectively neutralize virus that causes COVID-19
- Drug linked to 45% lower risk of dying among COVID-19 patients on ventilators
- Researchers call for worldwide biosurveillance network to protect from diseases
- New study supports remdesivir as COVID-19 treatment
- Neutralizing antibodies in the battle against COVID-19
- Remdesivir can save more lives where ICUs are overwhelmed
- Using Epo against COVID-19
Conferences & Events
- Wearable Injectors and Connected Devices Conference 2020
- Preparing for the new world of drug safety: Embracing cloud and AI
- Pre-filled Syringes San Francisco Conference 2020
- Oligonucleotide Therapeutics and Delivery Conference 2020
- Pre-Filled Syringes West Coast 2021
- Pre-Filled Syringes East Coast Conference 2020
- SMi's 4th Annual Pharmaceutical Microbiology West Coast
Regulatory Affairs
- FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
- FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
- FDA revokes emergency use authorization for chloroquine and hydroxychloroquine
- Global regulators commit to cooperate on observational research in the context of COVID-19
- FDA takes new actions to accelerate development of novel prevention, treatment options for COVID-19